Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New mouse models for human lung infections

Sep. 2, 2019

Beijing Kawin Technology Share-Holding discloses anti-IL-4RA antibodies

Aug. 30, 2019

Neutrophils stick with dipeptidase in lung, liver

Aug. 30, 2019

New global phase IIa study evaluates tezepelumab for moderate to very severe COPD

Aug. 27, 2019

Daewoong's pulmonary fibrosis drug DWN-12088 enters global phase I trial

Aug. 26, 2019

Phase II biomarker study of oral dexpramipexole in moderate to severe eosinophilic asthma

Aug. 20, 2019

CureVac, Yale to jointly discover mRNA-based candidates for pulmonary diseases

Aug. 14, 2019

Chiesi Farmaceutici initiates phase I study of CHF-6523 in COPD

Aug. 8, 2019

Positive phase II data presented for dry powder inhaler formulation of ensifentrine

Aug. 5, 2019

Arcturus receives additional support from CF Foundation to develop mRNA therapies to treat CF

Aug. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...